Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
ZERO, First Half Net Income Increases by 2.4 times, Oct-Dec Net Income Increases by 2.2 times
9028 ZERO CO.,LTD. 【IFRS】
Earnings ReportZERO CO.,LTD. <9028> [TSE Std] announced its financial results (based on IFRS) after the market closed on February 13th (17:00). The consolidated net income for the cumulative second quarter of the fiscal year ending June 2025 (July to December) surged 2.4 times that of the same period last year, reaching 3.5 billion yen. The progress rate toward the full-year plan of 5.5 billion yen was 63.7%, also surpassing the five-year average of 43.0%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income for the January to June period (2H) is expected to decrease 25.8% from the same period last year to 1.99 billion yen.
In the most recent three-month period, from October to December (2Q), the consolidated net income surged 2.2 times that of the same period last year, reaching 1.61 billion yen. The operating profit margin improved from 3.6% in the same period last year to 6.4%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2022 | 64,247 | 2,143 | 2,141 | 1,436 | 85.3 | 42.1 | Feb 9, 2023 | IFRS |
Jul - Dec, 2023 | 64,399 | 2,315 | 2,324 | 1,460 | 86.5 | 37.3 | Feb 8, 2024 | IFRS |
Jul - Dec, 2024 | 68,956 | 4,951 | 4,942 | 3,505 | 207.1 | 61.0 | Feb 13, 2025 | IFRS |
YoY | +7.1% | +113.9% | +112.7% | +140.1% | +139.4% |
First Half Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2024 Guidance | ー | ー | ー | ー | - | 43 | Aug 8, 2024 | IFRS |
Jul - Dec, 2024 Results | 68,956 | 4,951 | 4,942 | 3,505 | 207.1 | 43 | Feb 13, 2025 | IFRS |
Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 76,352 | 3,907 | 3,903 | 2,690 | 159.2 | 46.40 | Aug 8, 2024 | IFRS |
Jan - Jun, 2025 Guidance | 66,044 | 3,149 | 3,158 | 1,995 | 119.0 | 64.40 | Feb 13, 2025 | IFRS |
YoY | -13.5% | -19.4% | -19.1% | -25.8% | -25.3% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jun, 2023 | 132,861 | 5,074 | 5,080 | 3,437 | 204.0 | 51 | Aug 10, 2023 | IFRS |
Jun, 2024 | 140,751 | 6,222 | 6,227 | 4,150 | 245.6 | 61.40 | Aug 8, 2024 | IFRS |
Jun, 2025 Guidance | 135,000 | 8,100 | 8,100 | 5,500 | 328.0 | 107.40 | Aug 8, 2024 | IFRS |
YoY | -4.1% | +30.2% | +30.1% | +32.5% | +33.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 32,730 | 1,191 | 1,186 | 751 | 44.5 | 3.6 | Feb 8, 2024 | IFRS |
Jan - Mar, 2024 | 41,171 | 2,186 | 2,188 | 1,499 | 88.8 | 5.3 | May 9, 2024 | IFRS |
Apr - Jun, 2024 | 35,181 | 1,721 | 1,715 | 1,191 | 70.5 | 4.9 | Aug 8, 2024 | IFRS |
Jul - Sep, 2024 | 34,312 | 2,724 | 2,715 | 1,887 | 111.6 | 7.9 | Nov 7, 2024 | IFRS |
Oct - Dec, 2024 | 34,644 | 2,227 | 2,227 | 1,618 | 95.6 | 6.4 | Feb 13, 2025 | IFRS |
YoY | +5.8% | +87.0% | +87.8% | +115.4% | +114.9% |
Related Articles
Chiome Bioscience, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
e-LogiT, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Narrows, Oct-Dec Ordinary Profit Loss Narrows
Polaris Holdings, Oct-Dec (3Q) Ordinary Profit Increases by 32%
Hodogaya Chemical, Oct-Dec (3Q) Ordinary Profit Decreases by 78%
Columbia Works, 19% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Increased Previous Year's Dividend by 5 yen, This Fiscal Year to Increase Dividend by 23 yen
Obara Group, Oct-Dec (1Q) Ordinary Profit Increases by 29%
AMITA HOLDINGS, 36% Increase in Ordinary Profit, Record High for The First Time in Three Years, Dividend Raised by 1 yen
TOKYU, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 33%, Oct-Dec Ordinary Profit Increases by 32%
NITCHITSU, Oct-Dec (3Q) Ordinary Profit Increases by 12%
kaonavi, 64% Decrease in Ordinary Profit for The Current Fiscal Year